Clinical Trial Update: [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating [68Ga]Ga-P17-079 for diagnosing and treating metastatic prostate cancer is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [68Ga]Ga-P17-079

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Metastatic Prostate Cancer (mPC) | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION